
Selpercatinib (Retevmo)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.395
Subject(s) - sorafenib , lenvatinib , medicine , thyroid cancer , oncology , cancer , hepatocellular carcinoma